JAKARTA: The state-owned pharmaceutical maker PT Indofarma Tbk (INAF) estimates IDR1.1 trillion sales by end of this year.In a presentation material published to Indonesia Stock Exchange (IDX), Indofarma posted IDR850 billion sales by end of November 2010.Indofarma is expected to reach IDR47 billion operating profit and IDR10.64 billion net profit.The company plans to spend IDR59 billion capital expenditure in 2011. About 15% of the expenditure will be fulfilled by internally generated cash flow. (wiw)

Cek Berita dan Artikel yang lain di Google News dan WA Channel

---

Artikel Terkait

Berita Lainnya

Berita Terbaru